COMPANY
Kinea Bio, Inc.
Funding and NIH signals
- NIH award NIH awarded $1.02M (SBIR Phase II 4R44AR084978-02, extension, notice Sep 23, 2026); 3 NIH awards totaling $2.42M in the last 12 months. NIH RePORTER 4R44AR084978-02 (Sep 23, 2026)
Evidence (3 events)
- Sep 23, 2026 · NIH RePORTER 4R44AR084978-02
Organization: KINEA BIO, INC.; City/State: Mukilteo, WA; Project number: 4R44AR084978-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-23; FY total cost (award amount): 1021458; Administering IC: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Project title: Scalable Non-viral Gene Delivery for Neuromuscular Diseases; Organization type: Domestic For-Profits - Aug 28, 2026 · NIH RePORTER 1R44HL182563-01A1
Organization: KINEA BIO, INC.; City/State: Mukilteo, WA; Project number: 1R44HL182563-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-28; FY total cost (award amount): 599669; Administering IC: National Heart Lung and Blood Institute; Project title: Split-Intein Protein Ligation: Enabling AAV Delivery of Large Genes for Clinical Translation in Genetic Cardiac Diseases; Organization type: Domestic For-Profits - Jun 16, 2026 · NIH RePORTER 5R44AR083801-03
Organization: KINEA BIO, INC.; City/State: Mukilteo, WA; Project number: 5R44AR083801-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-16; FY total cost (award amount): 796218; Administering IC: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Project title: Development of novel genetic medicine approaches to treat orphan diseases; Organization type: Domestic For-Profits
- Sep 23, 2026 · NIH RePORTER 4R44AR084978-02